Angiotensin-(1-7) in kidney disease: A review of the controversies

Clinical Science

Volumn 123, Issue 6, 2012, Pages 333-346

  Zimmerman, Danielle ^a,b   Burns, Kevin D ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Angiotensin; Angiotensin converting enzyme 2 (ACE2); Diabetes; Kidney; Nephropathy; Proteinuria

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; IRBESARTAN; MLN 4760; N ETHYLCARBAMOYL 3 [4 (5 FORMYL 4 METHOXY 2 PHENYL 1 IMIDAZOLYLMETHYL)PHENYL] 5 ISOBUTYL 2 THIOPHENESULFONAMIDE; TELMISARTAN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANTIHYPERTENSIVE ACTIVITY; DIABETIC NEPHROPATHY; DRUG MEGADOSE; EPITHELIUM CELL; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

ANGIOTENSIN I; ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY DISEASES; MICE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84862561605     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120111     Document Type: Review

References (98)

1. Santos, R. A., Simoes e Silva, A. C., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V., Lopes, M. T., Bader, M. et al. (2003) Angiotensin-(1-7) is the endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. USA. 100, 8258-8263
2. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robinson, K., Jeyaseelan, R. et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-E9
3. Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G. and Turner, A. J. (2000) A human homologue of angiotensin converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275, 33238-33243
4. Locatelli, F., Del Vecchio, L. and Cavalli, A. (2009) Inhibition of the renin-angiotensin system in chronic kidney disease: a critical look to single and dual blockade. Nephron Clin. Pract. 113, c286-c293
5. Pugsley, M. K. (2005) The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes. Proc. West Pharmacol. Soc. 48, 35-38
6. Batlle, D., Wysocki, J., Soler, M. J. and Ranganath, K. (2012) Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy. Kidney Int. 6, 520-528
7. Tikellis, C., Bernardi, S. and Burns, W. C. (2011) Angiotensin converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Curr. Opin. Nephrol. Hypertens. 20, 62-68
8. Pendergrass, K. D., Pirro, N. T., Westwood, B. M., Ferrario, C. M., Brosnihan, K. B. and Chappell, M. C. (2008) Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats. Am. J. Physiol. Heart Circ. Physiol. 295, H10-H20
9. Ferrario, C. M., Martell, N., Yunis, C., Flack, J. M., Chappell, M. C., Brosnihan, K. B., Dean, R. H., Fernandez, A., Novikov, S. V., Pinillas, C. and Luque, M. (1998) Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am. J. Hypertens. 11, 137-146
10. Li, N., Zimpelmann, J., Cheng, K., Wilkins, J. A. and Burns, K. D. (2005) The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am. J. Physiol. Renal Physiol. 288, F353-F362
11. Soler, M. J., Ye, M., Wysocki, J., William, J., Lloveras, J. and Batlle, D. (2009) Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan. Am. J. Physiol. Renal Physiol. 296, F398-F405
12. Ye, M., Wysocki, J., William, J., Soler, M. J., Cokic, I. and Batlle, D. (2006) Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 17, 3067-3075
13. Ferrario, C. M. (2011) ACE2: more of Ang-(1-7) or less Ang II? Curr. Opin. Nephrol. Hypertens. 20, 1-6
14. Chappell, M. C., Pirro, N. T., Sykes, A. and Ferrario, C. M. (1998) Metabolism of angiotensin-(1-7) by angiotensin converting enzyme. Hypertension 31, 362-367
15. Iyer, S. N., Chappell, M. C., Averill, D. B., Diz, D. I. and Ferrario, C. M. (1998) Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 31, 699-705
16. Chappell, M. C., Allred, A. J. and Ferrario, C. M. (2001) Pathways of angiotensin-(1-7) metabolism in the kidney. Nephrol. Dial. Tranplant. 16, 22-26
17. Chappell, M. C., Brosnihan, K. B., Diz, D. I. and Ferrario, C. M. (1989) Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J. Biol. Chem. 264, 16518-16523
18. Alenina, N., Xu, P., Rentzsch, B., Patkin, E. L. and Bader, M. (2008) Genetically altered animal models for mas and angiotensin-(1-7). Exp. Physiol. 93, 528-537
19. Gwathmey, T. M., Westwood, B. M., Pirro, N. T., Tang, L., Rose, J. C., Diz, D. I. and Chappell, M. C. (2010) Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide. Am. J. Physiol. Renal Physiol. 299, F983-F990
20. Ren, Y., Garvin, J. L. and Carretero, O. A. (2002) Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 39, 799-802
21. Velkoska, E., Dean, R. G., Burchill, L., Levidiotis, V. and Burrell, L. M. (2010) Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition. Clin. Sci. 118, 269-279
22. da Silveira, K. D., Pompermayer Bosco, K.S.P., Diniz, L.R.L., Carmona, A. K., Cassali, G. D., Bruna-Romeros, O., de Sousa, L. P., Teixeira, M. M., Santos, R.A.S., Somões e Silva, A. C. and Vieira, M.A.R. (2010) ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion in rats. Clin. Sci. 119, 385-394
23. Tallant, E. A. and Clark, M. A. (2003) Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 42, 574-579
24. Tallant, E. A., Ferrario, C. M. and Gallagher, P. E. (2005) Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am. J. Physiol. Heart Circ. Physiol. 289, H1560-H1566
25. Sampaio, W. O., Henrique de Castro, C., Santos, R. A., Schiffrin, E. L. and Touyz, R. M. (2007) Angiotensin-(1-7) counterregulates angiotensin II signalling in human endothelial cells. Hypertension 50, 1093-1098
26. Andreatta-van Leyen, S., Romero, M. F., Khosla, M. C. and Douglas, J. G. (1993) Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). Kidney Int. 44, 932-936
27. Garcia, N. H. and Garvin, J. L. (1994) Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule. J. Am. Soc. Nephrol. 5, 1133-1138
28. + -ATPase activity via a A779-sensitive receptor. Regul. Pept. 103, 17-22
29. + -ATPase by Ang-(1-7). Biochem. J. 395, 183-190
30. + -ATPase activity by angiotensin(1-7) in pig kidneys. Exp. Physiol. 93, 639-647
31. Su, Z., Zimpelmann, J. and Burns, K. D. (2006) Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 69, 2212-2218
32. Gava, E., Samad-Zadeh, A., Zimpelmann, J., Bahramifarid, N., Kitten, G. T., Santos, R. A., Touyz, R. M. and Burns, K. D. (2009) Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose induced signalling in proximal tubular cells. Nephrol. Dial. Transplant. 24, 1766-1773
33. Burns, W. C., Velkoska, E., Dean, R., Burrell, L. M. and Thomas, M. C. (2009) Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by Ang 1-7/Mas-1-dependent pathways. Am. J. Physiol. Renal Physiol. 299, F585-F593
34. Zhou, L., Xue, H., Wang, Z., Ni, J., Yao, T., Huang, Y., Yu, C. and Lu, L. (2012) Angiotensin-(1-7) attenuates high glucose-induced proximal tubular epithelial-to-mesenchymal transition via inhibiting ERK1/2 and p38 phosphorylation. Life Sci. 90, 454-462
35. Zimpelmann, J. and Burns, K. D. (2009) Angiotensin-(1-7) activates growth stimulatory pathways in human mesangial cells. Am. J. Physiol. Renal Physiol 298, F337-F346
36. Liu, G. C., Oudit, G. Y., Fang, F., Zhou, J. and Scholey, J. W. (2012) Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. Am. J. Physiol. Renal Physiol. 302, F784-F790
37. Oudit, G. Y., Liu, G. C., Zhong, J. C., Basu, R., Chow, F. L., Zhou, J., Loibner, H., Janzek, E., Schuster, M., Penninger, J. M. et al. (2010) Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59, 529-538
38. Moon, J. Y., Tanimoto, M., Gohda, T., Hagiwara, S., Yamazaki, T., Ohara, I., Murakoshi, M., Aoki, T., Ishikawa, Y., Lee, S. H. et al. (2011) Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-Ay/Ta mice. Am. J. Physiol. Renal Physiol. 300, F1271-F1282
39. Velez, J. C., Bland, A. M., Arthur, J.M., Raymond, J. R. and Janech, M. G. (2007) Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am. J. Physiol. Renal Physiol. 293, F398-F407
40. de Andrade, M.C.C., Di Marco, G. S., Teixeira, V.P.C., Mortara, R. A., Sabatini, R. A., Pesquero, J. B., Boim, M. A., Carmona, A. K., Schor, N. and Casarini, D. E. (2006) Expression and localization of N-domain ANG I-converting enzymes in mesangial cells in culture from spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 290, F364-F375
41. van der Wouden, E. A., Ochodnický, P., van Dokkum, R. P., Roks, A. J., Deelman, L. E., de Zeeuw, D. and Henning, R. H. (2006) The role of angiotensin-(1-7) in renal vasculature of the rat. J. Hypertens. 24, 1971-1978
42. van Rodijnen, W. F., van Lambalgen, T. A., vanWijhe, M. H., Tangelder, G. J. and TerWee, P. M. (2002) Renal microvascular actions of angiotensin II fragments. Am. J. Physiol. Renal Physiol. 283, F86-F92
43. Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C. F., Heringer-Walther, S., Sexton, P. M., Gembardt, F., Kellett, E., Martini, L., Vanderheyden, P. et al. (2005) G-protein coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111, 1806-1813
44. Gonzales-Villalobos, R., Klassen, R. B., Allen, P. L., Johanson, K., Baker, C. B., Kobori, H., Navar, L. G. and Hammond, T. G. (2006) Megalin binds and internalizes angiotensin-(1-7). Am. J. Physiol. Renal Physiol. 290, F1270-F1275
45. Gironacci, M. M., Adamo, H. P., Corradi, G., Santos, R. A., Ortiz, P. and Carretero, O. A. (2011) Angiotensin (1-7) induces Mas receptor internalization. Hypertension 58, 176-181
46. Dong, X., Han, S., Zylka, M. J., Simon, M. I. and Anderson, D. J. (2001) A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106, 619-632
47. Katovich, M. J., Grobe, J. L. and Raizada, M. K. (2008) Angiotensin-(1-7) as an antihypertensive, antifibrotic target. Curr. Hypertens. Rep. 10, 227-232
48. Benter, I. F., Yousif, M. H., Anim, J. T., Cojocel, C. and Diz, D. I. (2006) Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am. J. Physiol. Heart Circ. Physiol. 290, H684-H691
49. Benter, I. F., Yousif, M. H., Cojocel, C., Al-Maghrebi, M. and Diz, D. I. (2007) Angiotensin-(1-7) prevents diabetes induced cardiovascular dysfunction. Am. J. Physiol. Heart. Circ. Physiol. 292, H666-H672
50. Giani, J. F., Muñoz, M. C., Mayer, M. A., Veiras, L. C., Arranz, C., Taira, C. A., Turyn, D., Toblli, J. E. and Dominici, F. P. (2010) Angiotensin-(1-7) improves cardiac remodelling and inhibits growth-promoting pathways in the heart of fructose-fed rats. Am. J. Physiol. Heart Circ. Physiol. 293, H1003-H1013
51. Zhang, J., Noble, N. A., Border, W. A. and Huang, Y. (2010) Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am. J. Physiol. Renal Physiol. 298, F579-F588
52. Benter, I. F., Diz, D. I. and Ferrario, C. M. (1993) Cardiovascular actions of angiotensin-(1-7). Peptides 14, 679-684
53. Benter, I. F., Ferrario, C. M., Morris, M. and Diz, D. I. (1995) Anti-hypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 269, H313-H319
54. Bürgelová, M., Vaňourková, Z., Thumová, M., Dvǒrák, P., Opočenský, M., Kramer, H. J., Želízko, M., Malý, J., Bader, M. and Červenka, L. (2009) Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-mas axis contributes to the acceleration of two-kidney, one-clip goldblatt hypertension. J. Hypertens. 27, 1988-2000
55. Rakušan, D., Bürgelová, M., Vaněčkova, I., Vaňourková, Z., Husková, Z., Škaroupková, P., Mrázová, I., Opočenský, M., Kramer, Z., Netuka, I. et al. (2010) Knockout of angiotensin (1-7) receptor mas worsens the course of two-kidney, one-clip goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II. Kidney Blood Press. Res. 33, 476-488
56. G-nitro-L-arginine methyl ester. J. Cardiovasc. Pharmacol. 57, 559-567
57. Giani, J. F., Muñoz, M. C., Pons, R. A., Cao, G., Toblli, J. E., Turyn, D. and Dominici, F. P. (2011) Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 300, F272-F282
58. Ji, H., Menini, S., Zheng, W., Pesce, C., Wu, X. and Sandberg, K. (2008) Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17β-estradiol regulation of renal pathology in renal wrap hypertension in rats. Exp. Phyiol. 93, 648-657
59. Benter, I. F., Yousif, M. H., Dhaunsi, G. S., Kaur, J., Chappell, M. C. and Diz, D. I. (2008) Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am. J. Nephrol. 28, 25-33
60. Dhaunsi, G. S., Yousif, M. H., Akhtar, S., Chappell, M. C., Diz, D. I. and Benter, I. F. (2010) Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities. Eur. J. Pharmacol. 638, 108-114
61. Wolf, G. and Ziyadeh, F. N. (2007) Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol. 106, 26-31
62. Singh, K., Singh, T. and Sharma, P. L. (2011) Beneficial effects of angiotensin (1-7) in diabetic rats with cardiomyopathy. Ther. Adv. Cardiovasc. Dis. 5, 159-167
63. Ebermann, L., Spillmann, F., Sidiropoulos, M., Escher, F., Heringer-Walther, S., Schultheiss, H. P., Tschöpe, C. and Walther, T. (2008) The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats. Eur. J. Pharmacol. 590, 276-280
64. Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J. and Cooper, M. E. (2003) Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41, 392-397
65. Tikellis, C., Bialkowski, K., Pete, J., Sheehy, K., Su, Q., Johnston, C., Cooper, M. E. and Thomas, M. C. (2008) ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 57, 1018-1025
66. Yamaleyeva, L. M., Gilliam-Davis, S., Almeida, I., Brosnihan, K. B., Lindsey, S. H. and Chappell, M. C. (2012) Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early onset diabetes. Am. J. Physiol. Renal Physiol., doi:10.1152/ajprenal.00656.2011
67. Wysocki, J., Ye, M., Soler, M. J., Gurley, S. B., Xiao, H. D., Bernstein, K. E., Coffman, T. M., Chen, S. and Batlle, D. (2006) ACE and ACE2 activity in diabetic mice. Diabetes 55, 2132-2139
68. Soler, M. J., Wysocki, J., Ye, M., Lloveras, J., Kanwar, Y. and Batlle, D. (2007) ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 72, 614-623
69. Mizuiri, S., Hemmi, H., Arita, M., Ohashi, Y., Tanaka, Y., Miyagi, M., Sakai, K., Ishikawa, Y., Shibuya, K., Hase, H. and Aikawa, A. (2008) Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am. J. Kidney Dis. 51, 613-623
70. Reich, H. N., Oudit, G. Y., Penninger, J. M., Scholey, J. W. and Herzenberg, A. M. (2008) Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 74, 1610-1616
71. Lakshmanan, A. P., Watanabe, K., Thandavarayn, R. A., Sari, F. R., Harima, M., Giridharan, V. V., Soetikno, V., Kodama, M. and Aizawa, Y. (2011) Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action. Free Radical Res. 45, 575-584
72. Shiota, A., Yamamoto, K., Ohishi, M., Tatara, Y., Ohnishi, M., Maekawa, Y., Iwamoto, Y., Takeda, M. and Rakugi, H. (2010) Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice. Hypertens. Res. 33, 298-307
73. Wong, D.W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M. and Scholey, J. W. (2007) Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol. 171, 438-451
74. Liu, C. X., Hu, Q., Wang, Y., Zhang, W., Ma, Z. Y., Feng, J. B., Wang, R., Wang, X. P., Dong, B., Gao, F. et al. (2011) Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Mol. Med. 17, 59-69
75. Ito, T., Tanimoto, M., Yamada, K., Kaneko, S., Matsumoto, M., Obayashi, K., Hagiwara, S., Murakoshi, M., Aoki, T., Wakabayashi, M. et al. (2006) Glomerular changes in the KK-ay/Ta mouse: a possible model for human type 2 diabetic nephropathy. Nephrology 11, 29-35
76. Shao, Y., He, M., Zhou, L., Yao, T., Huang, Y. and Lu, L. M. (2008) Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury. Acta Pharmacol. Sin. 29, 829-837
77. 2 receptor. Clin. Sci. 121, 297-303
78. van der Wouden, E. A., Henning, R. H., Deelman, L. E., Roks, A. J., Boomsma, F. and de Zeeuw, D. (2005) Does angiotensin (1-7) contribute to the anti-proteinuric effect of ACE-inhibitors. JRAAS 6, 96-101
79. Li, Y., Wu, J., He, Q., Shou, Z., Zhang, P., Pen, W., Zhu, Y. and Chen, J. (2009) Angiotensin (1-7) prevents heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice. Hypertens. Res. 32, 369-374
80. Dilauro, M., Zimpelmann, J., Robertson, S. J., Genest, D. and Burns, K. D. (2010) Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am. J. Physiol. Renal Physiol. 298, F1523-F1532
81. Velkoska, E., Dean, R. G., Griggs, K., Burchill, L. and Burrell, L. M. (2011) Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodeling in rats with subtotal nephrectomy. Clin. Sci. 120, 335-345
82. Mordwinkin, N. M., Russell, J. R., Burke, A. S., Dizerega, G. S., Louie, S. G. and Rodgers, K. E. (2012) Toxicological and toxicokinetic analysis of angiotensin (1-7) in two species. J. Pharm. Sci. 101, 373-380
83. Pinheiro, S. V., Ferreira, A. J., Kitten, G. T., da Silveira, K. D., da Silva, D. A., Santos, S. H., Gava, E., Castro, C. H., Magalhães, J. A., da Mota, R. K. et al. (2009) Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney Int. 75, 1184-1193
84. Esteban, V., Heringer-Walther, S., Sterner-Kock, A., de Bruin, R., van den Engel, S., Wang, Y., Mezzano, S., Egido, J., Schultheiss, H. P., Ruiz-Ortega, M. and Walther, T. (2009) Angiotensin-(1-7) and G protein coupled receptor Mas are key players in renal inflammation. PLos ONE 4, e5406
85. Simões e Silva, A., Diniz, J.S. S., Pereira, R. M., Pinheiro, S.V. B. and Santos, R.A.S. (2006) Circulating renin angiotensin system in childhood chronic renal failure: Marked increase of angiotensin-(1-7) in end-stage renal disease. Pediatr. Res. 60, 734-739
86. Mizuiri, S., Hemmi, H., Arita, M., Aoki, T., Ohashi, Y., Miyagi, M., Sakai, K., Shibuya, K., Hase, H. and Aikawa, A. (2011) Increased ACE and decreased ACE2 expression in kidneys from patients with IgA nephropathy. Nephron Clin. Pract. 117, c57-c66
87. Anderson, U. D., Olsson, M. G., Kristensen, K. H., Åkerström, B. and Hansson, S. R. (2012) Review: Biochemical markers to predict preeclampsia. Placenta 26, S42-S47
88. Roberts, J. M. and Hubel, C. A. (2009) The two stage model of preeclampsia: variations on the theme. Placenta 30, S32-S37
89. Anton, L., Merrill, D. C., Neves, L.A. A., Gruver, C., Moorefield, C. and Brosnihan, K. B. (2010) Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study. Reprod. Biol. Endocrinol. 8, 135
90. Brosnihan, K. B., Neves, L.A. A., Anton, L., Joyner, J., Valdés, G. and Merrill, D. C. (2004) Enhanced expression of Ang-(1-7) during pregnancy. Braz. J. Med. Biol. Res. 37, 1255-1262
91. Merrill, D. C., Karoly, M., Chen, K., Ferrario, C. M. and Brosnihan, K. B. (2002) Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 18, 239-245
92. Bharadwaj, M. S., Strawn, W. B., Groban, L., Yamaleyeva, L. M., Chappell, M. C., Horta, C., Atkins, K., Firmes, L., Gurley, S. B. and Brosnihan, K. B. (2011) Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction. Hypertension 58, 852-858
93. Joyner, J., Neves, L.A. A., Granger, J. P., Alexander, B. T., Merrill, D. C., Chappell, M. C., Ferrario, C. M., Davis, W. P. and Brosnihan, K. B. (2007) Temporal-spatial expression of Ang-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R169-R177
94. Waikar, S. S., Liu, K. D. and Chertow, G. M. (2007) The incidence and prognostic significance of acute kidney injury. Curr. Opin. Nephrol. Hypertens. 16, 227-236
95. Bonventre, J. V. and Yang, L. (2011) Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121, 4210-4221
96. Barroso, L. C., Silveira, K. D., Lima, C. X., Borges, V., Bader, M., Rachid, M., Santos, R.A.S, Souza, D. G., Somões e Silva, A. C. and Teixeira, M. M. (2012) Renoprotective effects of AVE0991, a nonpeptide Mas receptor agonist, in experimental acute renal injury. Int. J. Hypertens. 2012, 808726
97. Reule, S. and Gupta, S. (2011) Kidney regeneration and resident stem cells. Organogenesis 7, 135-139
98. Heringer-Walther, S., Eckert, K., Schumacher, S. M., Uharek, L., Wulf-Goldenburg, A., Gembardt, F., Fichtner, I., Schultheiss, H. P., Rodgers, K and Walther, T. (2009) Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 94, 857-860